Risperidone
Product Images NDC 55111-579

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Risperidone (NDC 55111-579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram1 (Diagram1)

An instructional line drawing showing the preparation of a liquid medication dose using a syringe and a vial. One hand holds the vial upside down, while the other hand pulls the syringe plunger downward to draw the liquid. This may demonstrate how to withdraw the medication from the vial before administration.*

FDA Label Image

Diagram2 (Diagram2)

An instructional illustration showing two hands drawing liquid into a syringe from a vial. The top hand pulls the syringe plunger upward while the bottom hand holds the vial upside down, indicating the technique for extracting medication.*

FDA Label Image

Diagram3 (Diagram3)

An instructional line drawing illustrating proper technique for withdrawing liquid medicine using an oral syringe. The image shows one hand holding a bottle and the other hand pulling the plunger of a syringe upwards from the bottle opening, indicating how to fill the syringe with medication.*

FDA Label Image

Table11 (Table11)

A data table showing tumor types, species, sex, and multiples of maximum human dose in mg/m² (mg/kg). It lists lowest effect level and highest no-effect level for pituitary adenomas, endocrine pancreas adenomas, mammary gland adenocarcinomas, and mammary gland neoplasm in mice and rats of both sexes.*

FDA Label Image

Carton (Carton)

Packaging label for Risperidone Oral Solution USP 1 mg/mL by Dr. Reddy's Laboratories Limited. The 30 mL carton includes usage details and storage instructions. The label notes the solution contains 1 mg risperidone per mL and has Rx only status. Manufacturing information for Dr. Reddy's and Bio-Pharm, Inc. is also present, along with barcode and lot/expiration fields.*

FDA Label Image

Container (Container)

Risperidone Oral Solution USP 1 mg/mL label from Dr. Reddy's Laboratories Limited. The 30 mL bottle label features dosage strength, NDC 55111-579-30, and usage instructions. The label includes storage instructions, manufacturer details, barcode, and prescription-only designation.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of the active ingredient Risperidone, showing its molecular framework with multiple rings, including a piperidine ring, and functional groups characteristic to its chemical identity.*

FDA Label Image

Table1 (Table1)

A data table listing adverse reaction percentages reported by patients taking Risperidone in doses of 2-8 mg/day and >8-16 mg/day compared to placebo. Reactions are categorized by system/organ class, including blood disorders, cardiac, ear, eye, gastrointestinal, general, immune, infections, investigations, metabolism, musculoskeletal, and nervous system disorders.*

FDA Label Image

Table1a (Table1a)

A data table presenting various adverse events categorized by disorder types, including Psychiatric Disorders, Renal and Urinary Disorders, Reproductive System and Breast Disorders, Respiratory, Thoracic and Mediastinal Disorders, Skin and Subcutaneous Tissue Disorders, and Vascular Disorders. The table details frequencies of specific symptoms such as insomnia, anxiety, urinary incontinence, nasal congestion, rash, and hypotension in different study groups or conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.